Global Infectious Disease Biomarker Testing Market 2024 by Company, Regions, Type and Application, Forecast to 2030
Page: 125
Published Date: 08 Jan 2024
Category: Medical Care
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
According to our (Global Info Research) latest study, the global Infectious Disease Biomarker Testing market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
The Global Info Research report includes an overview of the development of the Infectious Disease Biomarker Testing industry chain, the market status of Hospitals and Clinics (PCR, NGS), Diagnostic Centers (PCR, NGS), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Infectious Disease Biomarker Testing.
Regionally, the report analyzes the Infectious Disease Biomarker Testing markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Infectious Disease Biomarker Testing market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Infectious Disease Biomarker Testing market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Infectious Disease Biomarker Testing industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., PCR, NGS).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Infectious Disease Biomarker Testing market.
Regional Analysis: The report involves examining the Infectious Disease Biomarker Testing market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Infectious Disease Biomarker Testing market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Infectious Disease Biomarker Testing:
Company Analysis: Report covers individual Infectious Disease Biomarker Testing players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Infectious Disease Biomarker Testing This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals and Clinics, Diagnostic Centers).
Technology Analysis: Report covers specific technologies relevant to Infectious Disease Biomarker Testing. It assesses the current state, advancements, and potential future developments in Infectious Disease Biomarker Testing areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Infectious Disease Biomarker Testing market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Infectious Disease Biomarker Testing market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
PCR
NGS
ELISA or EIA
IHC
ISH
Others
Market segment by Application
Hospitals and Clinics
Diagnostic Centers
Academic Research Institutes
Others
Market segment by players, this report covers
Abacus Diagnostica
ALPCO
Abbott Laboratories
Agilent Technologies
Becton
Dickinson and Company
bioMérieux SA
Bio-Rad Laboratories
Danaher
F. Hoffmann-La Roche
Hologic
PerkinElmer
Qiagen
Quest Diagnostics Incorporated
Siemens Healthineers
Thermo Fisher Scientific
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Infectious Disease Biomarker Testing product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Infectious Disease Biomarker Testing, with revenue, gross margin and global market share of Infectious Disease Biomarker Testing from 2019 to 2024.
Chapter 3, the Infectious Disease Biomarker Testing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Infectious Disease Biomarker Testing market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Infectious Disease Biomarker Testing.
Chapter 13, to describe Infectious Disease Biomarker Testing research findings and conclusion.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope of Infectious Disease Biomarker Testing
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Infectious Disease Biomarker Testing by Type
1.3.1 Overview: Global Infectious Disease Biomarker Testing Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Infectious Disease Biomarker Testing Consumption Value Market Share by Type in 2023
1.3.3 PCR
1.3.4 NGS
1.3.5 ELISA or EIA
1.3.6 IHC
1.3.7 ISH
1.3.8 Others
1.4 Global Infectious Disease Biomarker Testing Market by Application
1.4.1 Overview: Global Infectious Disease Biomarker Testing Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospitals and Clinics
1.4.3 Diagnostic Centers
1.4.4 Academic Research Institutes
1.4.5 Others
1.5 Global Infectious Disease Biomarker Testing Market Size & Forecast
1.6 Global Infectious Disease Biomarker Testing Market Size and Forecast by Region
1.6.1 Global Infectious Disease Biomarker Testing Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Infectious Disease Biomarker Testing Market Size by Region, (2019-2030)
1.6.3 North America Infectious Disease Biomarker Testing Market Size and Prospect (2019-2030)
1.6.4 Europe Infectious Disease Biomarker Testing Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Infectious Disease Biomarker Testing Market Size and Prospect (2019-2030)
1.6.6 South America Infectious Disease Biomarker Testing Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Infectious Disease Biomarker Testing Market Size and Prospect (2019-2030)
2.1 Abacus Diagnostica
2.1.1 Abacus Diagnostica Details
2.1.2 Abacus Diagnostica Major Business
2.1.3 Abacus Diagnostica Infectious Disease Biomarker Testing Product and Solutions
2.1.4 Abacus Diagnostica Infectious Disease Biomarker Testing Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Abacus Diagnostica Recent Developments and Future Plans
2.2 ALPCO
2.2.1 ALPCO Details
2.2.2 ALPCO Major Business
2.2.3 ALPCO Infectious Disease Biomarker Testing Product and Solutions
2.2.4 ALPCO Infectious Disease Biomarker Testing Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 ALPCO Recent Developments and Future Plans
2.3 Abbott Laboratories
2.3.1 Abbott Laboratories Details
2.3.2 Abbott Laboratories Major Business
2.3.3 Abbott Laboratories Infectious Disease Biomarker Testing Product and Solutions
2.3.4 Abbott Laboratories Infectious Disease Biomarker Testing Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Abbott Laboratories Recent Developments and Future Plans
2.4 Agilent Technologies
2.4.1 Agilent Technologies Details
2.4.2 Agilent Technologies Major Business
2.4.3 Agilent Technologies Infectious Disease Biomarker Testing Product and Solutions
2.4.4 Agilent Technologies Infectious Disease Biomarker Testing Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Agilent Technologies Recent Developments and Future Plans
2.5 Becton
2.5.1 Becton Details
2.5.2 Becton Major Business
2.5.3 Becton Infectious Disease Biomarker Testing Product and Solutions
2.5.4 Becton Infectious Disease Biomarker Testing Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Becton Recent Developments and Future Plans
2.6 Dickinson and Company
2.6.1 Dickinson and Company Details
2.6.2 Dickinson and Company Major Business
2.6.3 Dickinson and Company Infectious Disease Biomarker Testing Product and Solutions
2.6.4 Dickinson and Company Infectious Disease Biomarker Testing Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Dickinson and Company Recent Developments and Future Plans
2.7 bioMérieux SA
2.7.1 bioMérieux SA Details
2.7.2 bioMérieux SA Major Business
2.7.3 bioMérieux SA Infectious Disease Biomarker Testing Product and Solutions
2.7.4 bioMérieux SA Infectious Disease Biomarker Testing Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 bioMérieux SA Recent Developments and Future Plans
2.8 Bio-Rad Laboratories
2.8.1 Bio-Rad Laboratories Details
2.8.2 Bio-Rad Laboratories Major Business
2.8.3 Bio-Rad Laboratories Infectious Disease Biomarker Testing Product and Solutions
2.8.4 Bio-Rad Laboratories Infectious Disease Biomarker Testing Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Bio-Rad Laboratories Recent Developments and Future Plans
2.9 Danaher
2.9.1 Danaher Details
2.9.2 Danaher Major Business
2.9.3 Danaher Infectious Disease Biomarker Testing Product and Solutions
2.9.4 Danaher Infectious Disease Biomarker Testing Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Danaher Recent Developments and Future Plans
2.10 F. Hoffmann-La Roche
2.10.1 F. Hoffmann-La Roche Details
2.10.2 F. Hoffmann-La Roche Major Business
2.10.3 F. Hoffmann-La Roche Infectious Disease Biomarker Testing Product and Solutions
2.10.4 F. Hoffmann-La Roche Infectious Disease Biomarker Testing Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 F. Hoffmann-La Roche Recent Developments and Future Plans
2.11 Hologic
2.11.1 Hologic Details
2.11.2 Hologic Major Business
2.11.3 Hologic Infectious Disease Biomarker Testing Product and Solutions
2.11.4 Hologic Infectious Disease Biomarker Testing Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Hologic Recent Developments and Future Plans
2.12 PerkinElmer
2.12.1 PerkinElmer Details
2.12.2 PerkinElmer Major Business
2.12.3 PerkinElmer Infectious Disease Biomarker Testing Product and Solutions
2.12.4 PerkinElmer Infectious Disease Biomarker Testing Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 PerkinElmer Recent Developments and Future Plans
2.13 Qiagen
2.13.1 Qiagen Details
2.13.2 Qiagen Major Business
2.13.3 Qiagen Infectious Disease Biomarker Testing Product and Solutions
2.13.4 Qiagen Infectious Disease Biomarker Testing Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Qiagen Recent Developments and Future Plans
2.14 Quest Diagnostics Incorporated
2.14.1 Quest Diagnostics Incorporated Details
2.14.2 Quest Diagnostics Incorporated Major Business
2.14.3 Quest Diagnostics Incorporated Infectious Disease Biomarker Testing Product and Solutions
2.14.4 Quest Diagnostics Incorporated Infectious Disease Biomarker Testing Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 Quest Diagnostics Incorporated Recent Developments and Future Plans
2.15 Siemens Healthineers
2.15.1 Siemens Healthineers Details
2.15.2 Siemens Healthineers Major Business
2.15.3 Siemens Healthineers Infectious Disease Biomarker Testing Product and Solutions
2.15.4 Siemens Healthineers Infectious Disease Biomarker Testing Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 Siemens Healthineers Recent Developments and Future Plans
2.16 Thermo Fisher Scientific
2.16.1 Thermo Fisher Scientific Details
2.16.2 Thermo Fisher Scientific Major Business
2.16.3 Thermo Fisher Scientific Infectious Disease Biomarker Testing Product and Solutions
2.16.4 Thermo Fisher Scientific Infectious Disease Biomarker Testing Revenue, Gross Margin and Market Share (2019-2024)
2.16.5 Thermo Fisher Scientific Recent Developments and Future Plans
3.1 Global Infectious Disease Biomarker Testing Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Infectious Disease Biomarker Testing by Company Revenue
3.2.2 Top 3 Infectious Disease Biomarker Testing Players Market Share in 2023
3.2.3 Top 6 Infectious Disease Biomarker Testing Players Market Share in 2023
3.3 Infectious Disease Biomarker Testing Market: Overall Company Footprint Analysis
3.3.1 Infectious Disease Biomarker Testing Market: Region Footprint
3.3.2 Infectious Disease Biomarker Testing Market: Company Product Type Footprint
3.3.3 Infectious Disease Biomarker Testing Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4.1 Global Infectious Disease Biomarker Testing Consumption Value and Market Share by Type (2019-2024)
4.2 Global Infectious Disease Biomarker Testing Market Forecast by Type (2025-2030)
5.1 Global Infectious Disease Biomarker Testing Consumption Value Market Share by Application (2019-2024)
5.2 Global Infectious Disease Biomarker Testing Market Forecast by Application (2025-2030)
6.1 North America Infectious Disease Biomarker Testing Consumption Value by Type (2019-2030)
6.2 North America Infectious Disease Biomarker Testing Consumption Value by Application (2019-2030)
6.3 North America Infectious Disease Biomarker Testing Market Size by Country
6.3.1 North America Infectious Disease Biomarker Testing Consumption Value by Country (2019-2030)
6.3.2 United States Infectious Disease Biomarker Testing Market Size and Forecast (2019-2030)
6.3.3 Canada Infectious Disease Biomarker Testing Market Size and Forecast (2019-2030)
6.3.4 Mexico Infectious Disease Biomarker Testing Market Size and Forecast (2019-2030)
7.1 Europe Infectious Disease Biomarker Testing Consumption Value by Type (2019-2030)
7.2 Europe Infectious Disease Biomarker Testing Consumption Value by Application (2019-2030)
7.3 Europe Infectious Disease Biomarker Testing Market Size by Country
7.3.1 Europe Infectious Disease Biomarker Testing Consumption Value by Country (2019-2030)
7.3.2 Germany Infectious Disease Biomarker Testing Market Size and Forecast (2019-2030)
7.3.3 France Infectious Disease Biomarker Testing Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Infectious Disease Biomarker Testing Market Size and Forecast (2019-2030)
7.3.5 Russia Infectious Disease Biomarker Testing Market Size and Forecast (2019-2030)
7.3.6 Italy Infectious Disease Biomarker Testing Market Size and Forecast (2019-2030)
8.1 Asia-Pacific Infectious Disease Biomarker Testing Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Infectious Disease Biomarker Testing Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Infectious Disease Biomarker Testing Market Size by Region
8.3.1 Asia-Pacific Infectious Disease Biomarker Testing Consumption Value by Region (2019-2030)
8.3.2 China Infectious Disease Biomarker Testing Market Size and Forecast (2019-2030)
8.3.3 Japan Infectious Disease Biomarker Testing Market Size and Forecast (2019-2030)
8.3.4 South Korea Infectious Disease Biomarker Testing Market Size and Forecast (2019-2030)
8.3.5 India Infectious Disease Biomarker Testing Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Infectious Disease Biomarker Testing Market Size and Forecast (2019-2030)
8.3.7 Australia Infectious Disease Biomarker Testing Market Size and Forecast (2019-2030)
9.1 South America Infectious Disease Biomarker Testing Consumption Value by Type (2019-2030)
9.2 South America Infectious Disease Biomarker Testing Consumption Value by Application (2019-2030)
9.3 South America Infectious Disease Biomarker Testing Market Size by Country
9.3.1 South America Infectious Disease Biomarker Testing Consumption Value by Country (2019-2030)
9.3.2 Brazil Infectious Disease Biomarker Testing Market Size and Forecast (2019-2030)
9.3.3 Argentina Infectious Disease Biomarker Testing Market Size and Forecast (2019-2030)
10.1 Middle East & Africa Infectious Disease Biomarker Testing Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Infectious Disease Biomarker Testing Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Infectious Disease Biomarker Testing Market Size by Country
10.3.1 Middle East & Africa Infectious Disease Biomarker Testing Consumption Value by Country (2019-2030)
10.3.2 Turkey Infectious Disease Biomarker Testing Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Infectious Disease Biomarker Testing Market Size and Forecast (2019-2030)
10.3.4 UAE Infectious Disease Biomarker Testing Market Size and Forecast (2019-2030)
11.1 Infectious Disease Biomarker Testing Market Drivers
11.2 Infectious Disease Biomarker Testing Market Restraints
11.3 Infectious Disease Biomarker Testing Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12.1 Infectious Disease Biomarker Testing Industry Chain
12.2 Infectious Disease Biomarker Testing Upstream Analysis
12.3 Infectious Disease Biomarker Testing Midstream Analysis
12.4 Infectious Disease Biomarker Testing Downstream Analysis
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global Infectious Disease Biomarker Testing Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Infectious Disease Biomarker Testing Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Infectious Disease Biomarker Testing Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Infectious Disease Biomarker Testing Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Abacus Diagnostica Company Information, Head Office, and Major Competitors
Table 6. Abacus Diagnostica Major Business
Table 7. Abacus Diagnostica Infectious Disease Biomarker Testing Product and Solutions
Table 8. Abacus Diagnostica Infectious Disease Biomarker Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Abacus Diagnostica Recent Developments and Future Plans
Table 10. ALPCO Company Information, Head Office, and Major Competitors
Table 11. ALPCO Major Business
Table 12. ALPCO Infectious Disease Biomarker Testing Product and Solutions
Table 13. ALPCO Infectious Disease Biomarker Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. ALPCO Recent Developments and Future Plans
Table 15. Abbott Laboratories Company Information, Head Office, and Major Competitors
Table 16. Abbott Laboratories Major Business
Table 17. Abbott Laboratories Infectious Disease Biomarker Testing Product and Solutions
Table 18. Abbott Laboratories Infectious Disease Biomarker Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Abbott Laboratories Recent Developments and Future Plans
Table 20. Agilent Technologies Company Information, Head Office, and Major Competitors
Table 21. Agilent Technologies Major Business
Table 22. Agilent Technologies Infectious Disease Biomarker Testing Product and Solutions
Table 23. Agilent Technologies Infectious Disease Biomarker Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Agilent Technologies Recent Developments and Future Plans
Table 25. Becton Company Information, Head Office, and Major Competitors
Table 26. Becton Major Business
Table 27. Becton Infectious Disease Biomarker Testing Product and Solutions
Table 28. Becton Infectious Disease Biomarker Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Becton Recent Developments and Future Plans
Table 30. Dickinson and Company Company Information, Head Office, and Major Competitors
Table 31. Dickinson and Company Major Business
Table 32. Dickinson and Company Infectious Disease Biomarker Testing Product and Solutions
Table 33. Dickinson and Company Infectious Disease Biomarker Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Dickinson and Company Recent Developments and Future Plans
Table 35. bioMérieux SA Company Information, Head Office, and Major Competitors
Table 36. bioMérieux SA Major Business
Table 37. bioMérieux SA Infectious Disease Biomarker Testing Product and Solutions
Table 38. bioMérieux SA Infectious Disease Biomarker Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. bioMérieux SA Recent Developments and Future Plans
Table 40. Bio-Rad Laboratories Company Information, Head Office, and Major Competitors
Table 41. Bio-Rad Laboratories Major Business
Table 42. Bio-Rad Laboratories Infectious Disease Biomarker Testing Product and Solutions
Table 43. Bio-Rad Laboratories Infectious Disease Biomarker Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Bio-Rad Laboratories Recent Developments and Future Plans
Table 45. Danaher Company Information, Head Office, and Major Competitors
Table 46. Danaher Major Business
Table 47. Danaher Infectious Disease Biomarker Testing Product and Solutions
Table 48. Danaher Infectious Disease Biomarker Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Danaher Recent Developments and Future Plans
Table 50. F. Hoffmann-La Roche Company Information, Head Office, and Major Competitors
Table 51. F. Hoffmann-La Roche Major Business
Table 52. F. Hoffmann-La Roche Infectious Disease Biomarker Testing Product and Solutions
Table 53. F. Hoffmann-La Roche Infectious Disease Biomarker Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. F. Hoffmann-La Roche Recent Developments and Future Plans
Table 55. Hologic Company Information, Head Office, and Major Competitors
Table 56. Hologic Major Business
Table 57. Hologic Infectious Disease Biomarker Testing Product and Solutions
Table 58. Hologic Infectious Disease Biomarker Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 59. Hologic Recent Developments and Future Plans
Table 60. PerkinElmer Company Information, Head Office, and Major Competitors
Table 61. PerkinElmer Major Business
Table 62. PerkinElmer Infectious Disease Biomarker Testing Product and Solutions
Table 63. PerkinElmer Infectious Disease Biomarker Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 64. PerkinElmer Recent Developments and Future Plans
Table 65. Qiagen Company Information, Head Office, and Major Competitors
Table 66. Qiagen Major Business
Table 67. Qiagen Infectious Disease Biomarker Testing Product and Solutions
Table 68. Qiagen Infectious Disease Biomarker Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 69. Qiagen Recent Developments and Future Plans
Table 70. Quest Diagnostics Incorporated Company Information, Head Office, and Major Competitors
Table 71. Quest Diagnostics Incorporated Major Business
Table 72. Quest Diagnostics Incorporated Infectious Disease Biomarker Testing Product and Solutions
Table 73. Quest Diagnostics Incorporated Infectious Disease Biomarker Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 74. Quest Diagnostics Incorporated Recent Developments and Future Plans
Table 75. Siemens Healthineers Company Information, Head Office, and Major Competitors
Table 76. Siemens Healthineers Major Business
Table 77. Siemens Healthineers Infectious Disease Biomarker Testing Product and Solutions
Table 78. Siemens Healthineers Infectious Disease Biomarker Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 79. Siemens Healthineers Recent Developments and Future Plans
Table 80. Thermo Fisher Scientific Company Information, Head Office, and Major Competitors
Table 81. Thermo Fisher Scientific Major Business
Table 82. Thermo Fisher Scientific Infectious Disease Biomarker Testing Product and Solutions
Table 83. Thermo Fisher Scientific Infectious Disease Biomarker Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 84. Thermo Fisher Scientific Recent Developments and Future Plans
Table 85. Global Infectious Disease Biomarker Testing Revenue (USD Million) by Players (2019-2024)
Table 86. Global Infectious Disease Biomarker Testing Revenue Share by Players (2019-2024)
Table 87. Breakdown of Infectious Disease Biomarker Testing by Company Type (Tier 1, Tier 2, and Tier 3)
Table 88. Market Position of Players in Infectious Disease Biomarker Testing, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 89. Head Office of Key Infectious Disease Biomarker Testing Players
Table 90. Infectious Disease Biomarker Testing Market: Company Product Type Footprint
Table 91. Infectious Disease Biomarker Testing Market: Company Product Application Footprint
Table 92. Infectious Disease Biomarker Testing New Market Entrants and Barriers to Market Entry
Table 93. Infectious Disease Biomarker Testing Mergers, Acquisition, Agreements, and Collaborations
Table 94. Global Infectious Disease Biomarker Testing Consumption Value (USD Million) by Type (2019-2024)
Table 95. Global Infectious Disease Biomarker Testing Consumption Value Share by Type (2019-2024)
Table 96. Global Infectious Disease Biomarker Testing Consumption Value Forecast by Type (2025-2030)
Table 97. Global Infectious Disease Biomarker Testing Consumption Value by Application (2019-2024)
Table 98. Global Infectious Disease Biomarker Testing Consumption Value Forecast by Application (2025-2030)
Table 99. North America Infectious Disease Biomarker Testing Consumption Value by Type (2019-2024) & (USD Million)
Table 100. North America Infectious Disease Biomarker Testing Consumption Value by Type (2025-2030) & (USD Million)
Table 101. North America Infectious Disease Biomarker Testing Consumption Value by Application (2019-2024) & (USD Million)
Table 102. North America Infectious Disease Biomarker Testing Consumption Value by Application (2025-2030) & (USD Million)
Table 103. North America Infectious Disease Biomarker Testing Consumption Value by Country (2019-2024) & (USD Million)
Table 104. North America Infectious Disease Biomarker Testing Consumption Value by Country (2025-2030) & (USD Million)
Table 105. Europe Infectious Disease Biomarker Testing Consumption Value by Type (2019-2024) & (USD Million)
Table 106. Europe Infectious Disease Biomarker Testing Consumption Value by Type (2025-2030) & (USD Million)
Table 107. Europe Infectious Disease Biomarker Testing Consumption Value by Application (2019-2024) & (USD Million)
Table 108. Europe Infectious Disease Biomarker Testing Consumption Value by Application (2025-2030) & (USD Million)
Table 109. Europe Infectious Disease Biomarker Testing Consumption Value by Country (2019-2024) & (USD Million)
Table 110. Europe Infectious Disease Biomarker Testing Consumption Value by Country (2025-2030) & (USD Million)
Table 111. Asia-Pacific Infectious Disease Biomarker Testing Consumption Value by Type (2019-2024) & (USD Million)
Table 112. Asia-Pacific Infectious Disease Biomarker Testing Consumption Value by Type (2025-2030) & (USD Million)
Table 113. Asia-Pacific Infectious Disease Biomarker Testing Consumption Value by Application (2019-2024) & (USD Million)
Table 114. Asia-Pacific Infectious Disease Biomarker Testing Consumption Value by Application (2025-2030) & (USD Million)
Table 115. Asia-Pacific Infectious Disease Biomarker Testing Consumption Value by Region (2019-2024) & (USD Million)
Table 116. Asia-Pacific Infectious Disease Biomarker Testing Consumption Value by Region (2025-2030) & (USD Million)
Table 117. South America Infectious Disease Biomarker Testing Consumption Value by Type (2019-2024) & (USD Million)
Table 118. South America Infectious Disease Biomarker Testing Consumption Value by Type (2025-2030) & (USD Million)
Table 119. South America Infectious Disease Biomarker Testing Consumption Value by Application (2019-2024) & (USD Million)
Table 120. South America Infectious Disease Biomarker Testing Consumption Value by Application (2025-2030) & (USD Million)
Table 121. South America Infectious Disease Biomarker Testing Consumption Value by Country (2019-2024) & (USD Million)
Table 122. South America Infectious Disease Biomarker Testing Consumption Value by Country (2025-2030) & (USD Million)
Table 123. Middle East & Africa Infectious Disease Biomarker Testing Consumption Value by Type (2019-2024) & (USD Million)
Table 124. Middle East & Africa Infectious Disease Biomarker Testing Consumption Value by Type (2025-2030) & (USD Million)
Table 125. Middle East & Africa Infectious Disease Biomarker Testing Consumption Value by Application (2019-2024) & (USD Million)
Table 126. Middle East & Africa Infectious Disease Biomarker Testing Consumption Value by Application (2025-2030) & (USD Million)
Table 127. Middle East & Africa Infectious Disease Biomarker Testing Consumption Value by Country (2019-2024) & (USD Million)
Table 128. Middle East & Africa Infectious Disease Biomarker Testing Consumption Value by Country (2025-2030) & (USD Million)
Table 129. Infectious Disease Biomarker Testing Raw Material
Table 130. Key Suppliers of Infectious Disease Biomarker Testing Raw Materials
List of Figures
Figure 1. Infectious Disease Biomarker Testing Picture
Figure 2. Global Infectious Disease Biomarker Testing Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Infectious Disease Biomarker Testing Consumption Value Market Share by Type in 2023
Figure 4. PCR
Figure 5. NGS
Figure 6. ELISA or EIA
Figure 7. IHC
Figure 8. ISH
Figure 9. Others
Figure 10. Global Infectious Disease Biomarker Testing Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 11. Infectious Disease Biomarker Testing Consumption Value Market Share by Application in 2023
Figure 12. Hospitals and Clinics Picture
Figure 13. Diagnostic Centers Picture
Figure 14. Academic Research Institutes Picture
Figure 15. Others Picture
Figure 16. Global Infectious Disease Biomarker Testing Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 17. Global Infectious Disease Biomarker Testing Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 18. Global Market Infectious Disease Biomarker Testing Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 19. Global Infectious Disease Biomarker Testing Consumption Value Market Share by Region (2019-2030)
Figure 20. Global Infectious Disease Biomarker Testing Consumption Value Market Share by Region in 2023
Figure 21. North America Infectious Disease Biomarker Testing Consumption Value (2019-2030) & (USD Million)
Figure 22. Europe Infectious Disease Biomarker Testing Consumption Value (2019-2030) & (USD Million)
Figure 23. Asia-Pacific Infectious Disease Biomarker Testing Consumption Value (2019-2030) & (USD Million)
Figure 24. South America Infectious Disease Biomarker Testing Consumption Value (2019-2030) & (USD Million)
Figure 25. Middle East and Africa Infectious Disease Biomarker Testing Consumption Value (2019-2030) & (USD Million)
Figure 26. Global Infectious Disease Biomarker Testing Revenue Share by Players in 2023
Figure 27. Infectious Disease Biomarker Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 28. Global Top 3 Players Infectious Disease Biomarker Testing Market Share in 2023
Figure 29. Global Top 6 Players Infectious Disease Biomarker Testing Market Share in 2023
Figure 30. Global Infectious Disease Biomarker Testing Consumption Value Share by Type (2019-2024)
Figure 31. Global Infectious Disease Biomarker Testing Market Share Forecast by Type (2025-2030)
Figure 32. Global Infectious Disease Biomarker Testing Consumption Value Share by Application (2019-2024)
Figure 33. Global Infectious Disease Biomarker Testing Market Share Forecast by Application (2025-2030)
Figure 34. North America Infectious Disease Biomarker Testing Consumption Value Market Share by Type (2019-2030)
Figure 35. North America Infectious Disease Biomarker Testing Consumption Value Market Share by Application (2019-2030)
Figure 36. North America Infectious Disease Biomarker Testing Consumption Value Market Share by Country (2019-2030)
Figure 37. United States Infectious Disease Biomarker Testing Consumption Value (2019-2030) & (USD Million)
Figure 38. Canada Infectious Disease Biomarker Testing Consumption Value (2019-2030) & (USD Million)
Figure 39. Mexico Infectious Disease Biomarker Testing Consumption Value (2019-2030) & (USD Million)
Figure 40. Europe Infectious Disease Biomarker Testing Consumption Value Market Share by Type (2019-2030)
Figure 41. Europe Infectious Disease Biomarker Testing Consumption Value Market Share by Application (2019-2030)
Figure 42. Europe Infectious Disease Biomarker Testing Consumption Value Market Share by Country (2019-2030)
Figure 43. Germany Infectious Disease Biomarker Testing Consumption Value (2019-2030) & (USD Million)
Figure 44. France Infectious Disease Biomarker Testing Consumption Value (2019-2030) & (USD Million)
Figure 45. United Kingdom Infectious Disease Biomarker Testing Consumption Value (2019-2030) & (USD Million)
Figure 46. Russia Infectious Disease Biomarker Testing Consumption Value (2019-2030) & (USD Million)
Figure 47. Italy Infectious Disease Biomarker Testing Consumption Value (2019-2030) & (USD Million)
Figure 48. Asia-Pacific Infectious Disease Biomarker Testing Consumption Value Market Share by Type (2019-2030)
Figure 49. Asia-Pacific Infectious Disease Biomarker Testing Consumption Value Market Share by Application (2019-2030)
Figure 50. Asia-Pacific Infectious Disease Biomarker Testing Consumption Value Market Share by Region (2019-2030)
Figure 51. China Infectious Disease Biomarker Testing Consumption Value (2019-2030) & (USD Million)
Figure 52. Japan Infectious Disease Biomarker Testing Consumption Value (2019-2030) & (USD Million)
Figure 53. South Korea Infectious Disease Biomarker Testing Consumption Value (2019-2030) & (USD Million)
Figure 54. India Infectious Disease Biomarker Testing Consumption Value (2019-2030) & (USD Million)
Figure 55. Southeast Asia Infectious Disease Biomarker Testing Consumption Value (2019-2030) & (USD Million)
Figure 56. Australia Infectious Disease Biomarker Testing Consumption Value (2019-2030) & (USD Million)
Figure 57. South America Infectious Disease Biomarker Testing Consumption Value Market Share by Type (2019-2030)
Figure 58. South America Infectious Disease Biomarker Testing Consumption Value Market Share by Application (2019-2030)
Figure 59. South America Infectious Disease Biomarker Testing Consumption Value Market Share by Country (2019-2030)
Figure 60. Brazil Infectious Disease Biomarker Testing Consumption Value (2019-2030) & (USD Million)
Figure 61. Argentina Infectious Disease Biomarker Testing Consumption Value (2019-2030) & (USD Million)
Figure 62. Middle East and Africa Infectious Disease Biomarker Testing Consumption Value Market Share by Type (2019-2030)
Figure 63. Middle East and Africa Infectious Disease Biomarker Testing Consumption Value Market Share by Application (2019-2030)
Figure 64. Middle East and Africa Infectious Disease Biomarker Testing Consumption Value Market Share by Country (2019-2030)
Figure 65. Turkey Infectious Disease Biomarker Testing Consumption Value (2019-2030) & (USD Million)
Figure 66. Saudi Arabia Infectious Disease Biomarker Testing Consumption Value (2019-2030) & (USD Million)
Figure 67. UAE Infectious Disease Biomarker Testing Consumption Value (2019-2030) & (USD Million)
Figure 68. Infectious Disease Biomarker Testing Market Drivers
Figure 69. Infectious Disease Biomarker Testing Market Restraints
Figure 70. Infectious Disease Biomarker Testing Market Trends
Figure 71. Porters Five Forces Analysis
Figure 72. Manufacturing Cost Structure Analysis of Infectious Disease Biomarker Testing in 2023
Figure 73. Manufacturing Process Analysis of Infectious Disease Biomarker Testing
Figure 74. Infectious Disease Biomarker Testing Industrial Chain
Figure 75. Methodology
Figure 76. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Abacus Diagnostica ALPCO Abbott Laboratories Agilent Technologies Becton Dickinson and Company bioMérieux SA Bio-Rad Laboratories Danaher F. Hoffmann-La Roche Hologic PerkinElmer Qiagen Quest Diagnostics Incorporated Siemens Healthineers Thermo Fisher Scientific
Related Reports
08 Jan 2023
Medical Care
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
